all-cis-5,8,11,14,17-icosapentaenoic acid/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Accumulates in liver
InsufficientEvidence strength: insufficient. Mechanistic inference, no evidence found, or evidence weakened below very limited.Finding“The amount of hepatic EPA of AHF + EPA group was increased 3.9- and 29-fold in comparison with the chow and AHF groups, respectively.”
Quoted verbatim from Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice.. - Study
- animal · not in humans
- Duration
- 4 weeks
- Dose
- EPA ethyl ester (95% grade) at 5% of the atherogenic high-fat diet, 4 weeks
- Population
- Male C57BL/6J mice fed an atherogenic high-fat diet supplemented with 5% EPA for four weeks, compared with chow and atherogenic high-fat diet alone
Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice.2016PMID:27333187Industry fundedPermalink
Keep reading
- Everything the graph holds on all-cis-5,8,11,14,17-icosapentaenoic acid
- Every compound studied against liver
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M45EJXHQW8T3CESDHCK1R10M